Serum Concentrations and Pharmacokinetics of Tranexamic Acid after Two Means of Topical Administration in Massive Weight Loss Skin-Reducing Surgery

• Published in: Plastic and reconstructive surgery (1963) Vol. 143; no. 6; p. 1169e
• Main Authors: Ausen, Kjersti, Pleym, Hilde, Liu, Jiayin, Hegstad, Solfrid, Nordgård, Håvard Bersås, Pavlovic, Ivan, Spigset, Olav
• Format: Journal Article
• Language: English
• Published: United States 01.06.2019
• Subjects: Abdominoplasty - methods; Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents - administration & dosage; Antifibrinolytic Agents - blood; Antifibrinolytic Agents - pharmacokinetics; Female; Humans; Infusions, Intravenous; Injections, Intralesional; Male; Middle Aged; Tranexamic Acid - administration & dosage; Tranexamic Acid - blood; Tranexamic Acid - pharmacokinetics; Weight Loss - physiology
• ISSN: 1529-4242
• DOI: 10.1097/PRS.0000000000005620

Topical administration of tranexamic acid to reduce bleeding is receiving increasing attention, as it is inexpensive, simple, and possibly beneficial in most surgery. Concerns regarding potential systemic adverse effects such as thromboembolic events and seizures may prevent general use of tranexamic acid. Although serum concentrations after topical application are assumed to be low, proper pharmacokinetic studies of tranexamic acid after topical application are lacking. The authors have investigated systemic absorption of tranexamic acid after two means of topical administration in patients undergoing abdominoplasty after massive weight loss: a bolus of 200 ml of 5 mg/ml into the wound cavity versus moistening the wound surface with 20 ml of 25 mg/ml. Twelve patients were recruited in each group. Serum concentrations achieved were compared with those after administration of 1 g as an intravenous bolus to arthroplasty patients. Serial blood samples for tranexamic acid analysis were obtained for up to 24 hours. After intravenous administration, the peak serum concentration was 66.1 ± 13.0 µg/ml after 6 ± 2 minutes. Peak serum concentration after topical moistening was 5.2 ± 2.6 µg/ml after 80 ± 33 minutes, and in the topical bolus group, it was 4.9 ± 1.8 µg/ml after 359 ± 70 minutes. Topical moistening resulted in homogenous and predictable absorption across the individuals included, whereas topical bolus administration caused variable and unpredictable serum concentrations. Topical administration of tranexamic acid in patients undergoing abdominoplasty results in low serum concentrations, which are highly unlikely to cause systemic effects.